Smith Group Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-110	Closed	-$5K	–	300
2021 Q4	$5K	Hold	110	–	–	﹤0.01%	341
2021 Q3	$6K	Buy	+110	New	+$6K	﹤0.01%	341